Xaira Therapeutics, an AI-enabled drug discovery and development company, announced its launch with more than $1 billion in capital. The biotechnology company is a joint incubation by ARCH Venture Partners and Foresite Labs, the lead…
Continue Reading
Abridge, the leader in generative AI for clinical documentation, announced an additional $150 million investment, leveraging momentum from their product’s rapid uptake among health systems throughout the nation. This raise comes just 4 months…
Continue Reading
Top News
AI clinical documentation company Abridge raises $150 million in a Series C funding round co-led by Lightspeed Venture Partners. Lightspeed Advisor Paul Ricci is a former chairman and CEO of Nuance, one of…
Continue Reading
What You Should Know:
– Abridge, the leading force in generative AI for clinical documentation, announced today a staggering $150 million Series C funding round led by Lightspeed Venture Partners. The funding also includes participation…
Continue Reading
Investment Fuels Innovation to Ensure Patient Safety and Validate the Use of AI in Medical Devices
Ketryx, provider of the first and only connected application lifecycle management software for the life sciences industry, today announced…
The FDA recalled 60 medical devices last year, and the running total for this year is 56. The good news is that there’s a startup working to make future totals lower.
The startup, named Ketryx,…
Daybreak Health, a digital mental health company for children and teens focused on schools, has raised $13 million in Series B funding led by Union Square Ventures, bringing its total raise to $25 million. Existing…
Continue Reading
Earlier this year, U.S. Surgeon General Vivek Murthy described the worsening mental health symptoms among the country’s youth as the “defining public health crisis of our time.” On Tuesday, investors poured $13 million into…
Continue Reading
